The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles
Open accessAbstract
Magnetic iron oxide nanoparticles (MNPs) have been studied to circumvent the limitations of status-quo brain tumor therapy and can be targeted by applying an external magnetic field to lesions. To address the pharmacokinetic challenges of MNPs that can limit targeting efficiency, we recently reported a long-circulating polyethylene glycol modified, cross-linked starch MNP (PEG-MNP) suitable for magnetic targeting. Using a rat model, this work explores the biodistribution patterns of PEG-MNPs in organs of elimination (liver, spleen, lung, and kidney) and shows proof-of-concept that enhanced magnetic brain tumor targeting can be achieved due to improvements in the circulation lifetime of MNPs. Reductions in liver (~12 fold) and spleen (~2.5 fold) concentrations at 1 hr compared to parent starch MNPs (D) confirm plasma pharmacokinetics observed previously. While liver concentrations of PEG-MNPs remained considerably lower than those observed for D at 1 hr throughout their plasma clearance, spleen values continue to increase through and are markedly higher at 12 and 60 hr – a trend also observed with histology. Limited to no uptake of PEG-MNPs was visualized in lung or kidney throughout the 60 hr course evaluated. Enhanced, selective magnetic brain tumor targeting (t = 1 hr, 12 mg Fe/kg) of PEG-MNPs was confirmed in 9L glioma tumors, with upto 1.0% injected dose/g tissue accumulation achieved – a 15-fold improvement over targeted D (0.07% injected dose/g tissue). MRI and histological analyses visually confirmed enhanced PEG-MNP delivery to tumors and also suggest limited passive contribution to tissue retention of nanoparticles. Nonetheless, our results are exciting and justify both further development of PEG-MNP as a drug delivery platform and concurrent optimization of the magnetic brain tumor targeting strategy utilized.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In vivo imaging of siRNA delivery and silencing in tumors
Medarova, Z., Pham, W., Farrar, C., Petkova, V., & Moore, A. (2007) · Nature Medicine · doi:10.1038/nm1486 · Cited by 697
Cole, A. J., David, A. E., Wang, J., Galbán, C. J., Hill, H. L., & Yang, V. C. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.11.040 · Cited by 308
Self-citation
Research works printed but not linked: 25
- Sanai, 2010, Intraoperative stimulation techniques for functional pathway preservation and glioma resection, Neurosurg Focus, 28, E1, 10.3171/2009.12.FOCUS09266 · DOI · Paper page
- Sathornsumetee, 2007, Molecularly targeted therapy for malignant glioma, Cancer, 110, 13, 10.1002/cncr.22741 · DOI · Paper page
- Agrawal, 2009, Functional delivery of siRNA in mice using dendriworms, ACS Nano, 3, 2495, 10.1021/nn900201e · DOI
- Hadjipanayis, 2010, EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma, Cancer Res, 70, 6303, 10.1158/0008-5472.CAN-10-1022 · DOI · Paper page
- Veiseh, 2009, Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier, Cancer Res, 69, 6200, 10.1158/0008-5472.CAN-09-1157 · DOI · Paper page
- Liu, 2010, Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain, Proc Natl Acad Sci U S A, 107, 15205, 10.1073/pnas.1003388107 · DOI · Paper page
- Cole AJ, Yang VC, David AE. Cancer theranostics: the rise of targeted magnetic nanoparticles. Trends Biotechnol, in press, doi:10.1016/j.tibtech.2011.03.001. · DOI · Paper page
- Pankhurst, 2003, Applications of magnetic nanoparticles in biomedicine, J Phys D-Appl Phys, 36, R167, 10.1088/0022-3727/36/13/201 · DOI · Paper page
- Dobson, 2006, Magnetic nanoparticles for drug delivery, Drug Dev Res, 67, 55, 10.1002/ddr.20067 · DOI · Paper page
- Chertok, 2007, Glioma selectivity of magnetically targeted nanoparticles: a role of abnormal tumor hydrodynamics, J Control Release, 122, 315, 10.1016/j.jconrel.2007.05.030 · DOI
- Chertok, 2009, Substantiating in vivo magnetic brain tumor targeting of cationic iron oxide nanocarriers via adsorptive surface masking, Biomaterials, 30, 6780, 10.1016/j.biomaterials.2009.08.040 · DOI
- Chertok, 2010, Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration, Biomaterials, 31, 6317, 10.1016/j.biomaterials.2010.04.043 · DOI · Paper page
- Chertok, 2008, Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors, Biomaterials, 29, 487, 10.1016/j.biomaterials.2007.08.050 · DOI · Paper page
- David AE, Cole AJ, Chertok B, Park YS, Yang VC. A combined theoretical and in vitro modeling approach for predicting the magnetic capture and retention of magnetic nanoparticles in vivo. J Control Release, in press, doi:10.1016/j.jconrel.2011.01.033. · DOI
- Zhang, 2009, Gum Arabic-coated magnetic nanoparticles for potential application in simultaneous magnetic targeting and tumor imaging, AAPS J, 11, 693, 10.1208/s12248-009-9151-y · DOI
- Lee, 2010, Rapid pharmacokinetic and biodistribution studies using cholorotoxin-conjugated iron oxide nanoparticles: a novel non-radioactive method, PLoS ONE, 5, e9536, 10.1371/journal.pone.0009536 · DOI
- Jain, 2008, Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats, Mol Pharm, 5, 316, 10.1021/mp7001285 · DOI · Paper page
- Gupta, 2004, Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies, IEEE Trans Nanobiosci, 3, 66, 10.1109/TNB.2003.820277 · DOI · Paper page
- Goya, 2008, Magnetic nanoparticles for cancer therapy, Curr Nanosci, 4, 1, 10.2174/157341308783591861 · DOI · Paper page
- Chertok, 2010, Comparison of electron spin resonance spectroscopy and inductively-coupled plasma optical emission spectroscopy for biodistribution analysis of iron-oxide nanoparticles, Mol Pharm, 7, 375, 10.1021/mp900161h · DOI
- Ross, 1998, Contributions of cell kill and posttreatment tumor growth rates to the repopulation of intracerebral 9L tumors after chemotherapy: an MRI study, Proc Natl Acad Sci U S A, 95, 7012, 10.1073/pnas.95.12.7012 · DOI
- Huang, 2009, Bioavailability of magnetic nanoparticles to the brain, J Magn Magn Mater, 321, 1604, 10.1016/j.jmmm.2009.02.095 · DOI
- McCuskey, 1987, Kupffer cell-function in host defense, Rev Infect Dis, 9, S616, 10.1093/clinids/9.Supplement_5.S616 · DOI
- Senior, 2010, Unintended hepatic adverse events associated with cancer chemotherapy, Toxicol Pathol, 38, 142, 10.1177/0192623309351719 · DOI · Paper page
- Lampson, 2009, Targeted therapy for neuro-oncology: reviewing the menu, Drug Discov Today, 14, 185, 10.1016/j.drudis.2008.11.003 · DOI
Cited by
Progress and challenges towards targeted delivery of cancer therapeutics
Rosenblum, D., Joshi, N., Tao, W., Karp, J. M., & Peer, D. (2018) · Nature Communications · doi:10.1038/s41467-018-03705-y · Cited by 2,220
Wu, W., Wu, Z., Yu, T., Jiang, C., & Kim, W.-S. (2015) · Science and Technology of Advanced Materials · doi:10.1088/1468-6996/16/2/023501 · Cited by 1,574
Iron Oxide Based Nanoparticles for Multimodal Imaging and Magnetoresponsive Therapy
Lee, N., Yoo, D., Ling, D., Cho, M. H., Hyeon, T., & Cheon, J. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00112 · Cited by 1,005
In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles
Arami, H., Khandhar, A., Liggitt, D., & Krishnan, K. M. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00541h · Cited by 830
PLGA: a Unique Polymer for Drug Delivery
Kapoor, D. N., Bhatia, A., Kaur, R., Sharma, R., Kaur, G., & Dhawan, S. (2015) · Therapeutic Delivery · doi:10.4155/tde.14.91 · Cited by 609
Metadata
- Authors
- Cole, A. J., David, A. E., Wang, J., Galbán, C. J., & Yang, V. C.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 32
- Issue
- 26
- Pages
- 6291-6301
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2015537219
- Cited by
- 238
- References
- 2
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Funders
- National Institutes of Health (NIH) (CA114612, NS066945)
- Hartwell Foundation Biomedical Research Award
- World Class University (WCU) (R31-2008-000-10103-01)
- National Basic Research Program of China (2007CB935800)
- NIH Pharmacological Sciences and Bio-related Chemistry Training Grant (GM007767)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles. https://app.cochat.ai/papers/10.1016/j.biomaterials.2011.05.024
- The paper
- Cole, A. J., David, A. E., Wang, J., Galbán, C. J., & Yang, V. C. (2011). Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles. Biomaterials. https://doi.org/10.1016/j.biomaterials.2011.05.024
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.